Wyeth (WYE) Gets Approvable Letter for Osteoporosis Drug (BioSpace, 26 December 2007)

08 Jan 2008

Wyeth Pharmaceuticals have announced that the U.S. Food and Drug Administration has issued a second approvable letter for bazedoxifene, a selective estrogen receptor modulator, for the prevention of postmenopausal osteoporosis.